Terry Campbell

Terry Campbell has worked in the biotechnology industry since 2008. Terry began their career at Sanofi Pasteur as a Senior Research Virologist in Global Clinical Immunology. In 2012, they moved to Charles River Laboratories, where they held the roles of Developmental Scientist, Virology; Supervisor, Virology Operations; and Supervisor of Microbiology and Environmental Monitoring. In 2017, they joined Merck as a Senior Specialist in Vaccine Support. In 2018, they began working at WuXi Advanced Therapies as a Director, Virology Operations, Viral Vector Gene Therapies, and later held the roles of Associate Director and Manager. Most recently, in 2021, they joined Imvax, Inc. as a QC Testing Lead for Analytical and Microbiology Testing.

Terry Campbell obtained a Bachelor's degree in Molecular Biology from the University of Scranton in 2007, having studied there from 2003-2007. Terry then went on to pursue a Master of Business Administration (MBA) at the University of Scranton, though the start and end years for this degree are currently unknown.